Guía argentina de urticaria y angioedema / Argentine guidelines for urticaria and angioedema
Medicina (B.Aires)
; 74 Suppl 1: 1-53, 2014.
Article
in Es
| LILACS, BINACIS
| ID: biblio-1165174
Responsible library:
BR1.1
Localization: [{"text": "AR5.1"}]
ABSTRACT
This interdisciplinary paper summarizes the news in the diagnosis and treatment of chronic urticaria (CU), and provides concepts, definitions and evidence-based suggestions for its management. Urticaria occurs in at least 20
RESUMO
of patients do not achieve good control despite increased doses and require additional treatment. The most recent evidence indicates a group of drugs to be used as third line in these cases, to improve quality of life and to limit toxicity from frequent or chronic use of systemic steroids. Only 3 drugs are recommended as third line omalizumab, cyclosporin A or anti-leukotrienes.
Full text:
1
Index:
LILACS
Main subject:
Urticaria
/
Anti-Allergic Agents
/
Histamine Antagonists
Type of study:
Diagnostic_studies
/
Guideline
Limits:
Humans
Country/Region as subject:
America do sul
/
Argentina
Language:
Es
Journal:
Medicina (B.Aires)
Journal subject:
MEDICINA
Year:
2014
Type:
Article